Hold at ~$355 with calendar-based trim architecture: 20-25% trim at Q4 FY26 earnings and December FOMC; add trigger above $370.65 on volume; hard stop $336
Hold AVGO at ~$355. The fundamentals (85% YoY revenue growth, EPS tripling to $2.68, 75.5% gross margins, 0.34 PEG ratio) are extraordinary but well-recognized and priced in. The forward EPS arithmetic remains the binding constraint (Q4 FY26 requires +223% YoY to validate consensus), but the developing basing pattern (RSI higher lows 32→39→47, MACD histogram nine positive readings in ten sessions, ATR compressed 34%) preserves upside optionality. Calendar-based trim pre-commits (20-25% at Q4 earnings + 20-25% at December FOMC) force action at known catalysts and neutralize the bleeding-Hold failure mode while preserving the trader's technical framework. Honest near-term R/R is 1:1 to 2:1 (4-5% upside to $366-370 vs 10-15% downside to $310-320 if $336 fails).
| Position | Action |
|---|---|
| Current position | Hold weight through basing pattern; no additions until confirmed close >$370.65 on ≥30M shares |
| Q4 FY26 earnings (early December) | Pre-committed 20-25% trim |
| December FOMC | Pre-committed 20-25% trim |
| Confirmed loss of $336.91 lower Bollinger on expanding volume | Trim 25-50% |
| $366 close (200 SMA reclaim) on volume >18M AND RSI>50 | Re-engage/build position |
| Flush to $300-320 with stabilization (hammer, RSI<30, declining volume) | Asymmetric Buy setup |
AVGO presents an asymmetric risk/reward opportunity at $355 as technical momentum diverges from price (MACD bullish crossover, RSI higher-lows), revenue accelerates 85% YoY with EPS nearly tripling, PEG ratio of 0.34 signals undervaluation relative to growth, and the Anthropic IPO creates a new multi-billion dollar customer while debt deleveraging compounds earnings power into Q4 FY26 earnings.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 352.34 (+0.8%) | neutral |
| 50 SMA | 372.67 (-4.7%) | bearish |
| 200 SMA | 366.26 (-3.0%) | bearish |
| RSI(14) | 47.85 | neutral |
| MACD | -5.33 | bullish |
| MACD Signal | -6.29 | neutral |
| MACD Histogram | +0.96 | bullish |
| Bollinger Upper (20,2) | 370.65 | neutral |
| Bollinger Middle (20 SMA) | 353.78 | neutral |
| Bollinger Lower (20,2) | 336.91 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $366 close (200 SMA reclaim) on volume >18M AND RSI>50
Then: Rebuild position
Forward valuation is compelling with PEG of 0.34 — the market is paying a cyclical multiple for hypergrowth
EV: +14–40%
AVGO's 28% drawdown is not a bottom but a bear-market rally—the technicals remain bearish (price below both SMAs, death cross confirmed), the forward EPS estimate of $19.38 is heroic (requiring Q4 EPS of $8.66 from a company that has never exceeded $2.68/quarter), and customer concentration in 2-3 hyperscalers building in-house silicon alternatives creates structural risk.
· concedes: Q3 FY26 revenue was +85% YoY (though distorted by VMware acquisition timing); Sentiment is not euphoric (though this reflects lack of buying interest, not contrarian opportunity); Volatility has compressed (though this is symmetric and favors trend continuation when below declining SMAs)
→ vs conservative: Death cross, negative MACD at minus 5.33, lower highs pattern, 28 percent drawdown, and 45x trailing P/E are dismissed as surface-level concerns that miss the forward-looking picture; MACD histogram showing nine positive readings in ten sessions and RSI forming higher lows contradict structural decline narrative
→ vs conservative: Trailing P/E anchoring is fundamentally irrelevant; forward P/E of 18x and PEG of 0.34 make this one of the most mispriced quality growth names; conservative framework caused investors to miss 2023-2025 rally; VMware integration accounting noise artificially compresses TTM figures
→ vs neutral: Waiting for breakout above 370.65 with 30 million shares of volume forfeits highest expected value portion of move; by the time confirmation arrives, stock will be at 385-395 and risk reward will have compressed dramatically
→ vs neutral: Q4 FY26 earnings as binary catalyst justification for waiting is wrong; Q3 demonstrated 85 percent revenue acceleration, tripling EPS, 69 percent gross margin, and 5.6 billion debt paydown; Anthropic IPO and AI capex data reinforce bull case
→ vs neutral: Setup is asymmetric not binary; waiting for confirmation is not neutral, it is implicitly bearish as it assumes conservative outcome is more likely than bullish, which the data does not support
| ATR(14) |
| 10.87 |
| neutral |
Support: 336.91 · 343 · 317 · 320 | Resistance: 366.26 · 370.65 · 383 · 390
AVGO is in a corrective phase after declining 28% from its $493.32 June 2026 peak to current levels near $355.14. The 50 SMA and 200 SMA remain above price, confirming a bearish trend structure, though MACD histogram has been positive for 9 of the last 10 sessions and RSI has recovered from oversold (32.27 on Sept 15) to neutral (47.85), forming a constructive higher-low pattern. Bollinger Bands have contracted sharply (upper band fell from $442.94 to $370.65) and ATR compressed ~34%, indicating volatility contraction consistent with base-building. Key resistance sits at $370.65 (Bollinger upper) and $366.26 (200 SMA), while critical support is at $336.91 (Bollinger lower). The tactical bias is HOLD with a bullish lean pending breakout confirmation above $370.65.
Market Cap
$1.695 trillion
P/E (TTM)
45.36x
Forward P/E
18.32x
PEG Ratio
0.34
P/B
17.01x
EPS (TTM)
$7.83
Forward EPS
$19.38
Dividend Yield
0.76%
Beta
1.457
52-Wk High
$495.00
52-Wk Low
$289.96
Revenue (TTM)
$89.10B
Gross Margin
~75.5%
Operating Margin
54.31%
Net Margin
42.94%
EBITDA Margin
~58.6%
ROE
44.25%
ROA
15.37%
Q3 FY26 Revenue
$29.59B (+85% YoY)
Q3 FY26 Net Income
$13.09B
Q3 FY26 Diluted EPS
$2.68
Cash (Q3 FY26)
$23.98B
Net Debt (Q3 FY26)
$35.44B
Stockholders' Equity
$99.69B
Current Ratio
2.50
Net Debt / EBITDA
~0.68x
Operating CF (FY25)
$27.54B
Free Cash Flow (FY25)
$26.91B
Dividends Paid (FY25)
$11.14B
Buybacks (FY25)
$6.31B
Implied EPS Growth
~+147%
Strengths
Concerns
Broadcom is in its strongest fundamental position in history, with Q3 FY26 revenue of $29.59B surging 85% YoY driven by AI-XPU custom accelerator sales to hyperscalers and VMware synergies. The valuation dichotomy between 45x trailing P/E and 18.32x forward P/E (with 0.34 PEG ratio) reflects depressed TTM EPS from VMware acquisition accounting and one-time tax items, while forward consensus of $19.38 EPS implies ~147% growth. The company operates one of the highest-margin business models in semiconductors (54.31% operating margin, 44.25% ROE), generates exceptional FCF (~75-80% conversion), and is rapidly deleveraging with net debt/EBITDA of just 0.68x. The secular AI capex tailwind combined with recurring VMware software cash flows and aggressive capital returns creates a compelling compounder profile for patient capital.
Macro: A classic "Goldilocks soft landing" backdrop is consolidating—disinflationary September jobs miss (+0.3M actual vs. consensus), dovish Fed repricing with 96% probability of zero 2026 rate cuts, and low 8% recession odds by year-end 2026. Geopolitically, active Iran conflict poses an inflationary tail risk via oil/supply chains, though formal US war declaration remains only 3% probable. Lower Treasury yields post-jobs-miss and fading rate-hike expectations provide a supportive macro environment for high-multiple AI semiconductors like AVGO.